Keke Huang
No. 218, Jixi Road
Hefei, China
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Pretreatment TyG-BMI predicts CD19 CAR-T persistence and prognosis in diffuse large B-cell lymphoma.
Pretreatment TyG-BMI predicts CD19 CAR-T persistence and prognosis in diffuse large B-cell lymphoma.
Journal: Frontiers in oncology
Published: June 30, 2026
Co-expression of CCR7 and H3K9me3 identifies aggressive B-cell lymphoma with bone marrow infiltration and poor prognosis.
Journal: European cytokine network
Published: December 18, 2025
CBX7 regulates chemotherapy-induced senescence-like growth arrest in multiple myeloma via the ERK/STAT3/PIM1 axis.
Journal: Journal of translational medicine
Published: July 03, 2025
A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma.
Journal: Scientific reports
Published: July 05, 2024
MSRB2 Ameliorates H2O2-induced Chondrocyte Oxidative Stress and Suppresses Apoptosis in Osteoarthritis.
Journal: Immunological investigations
Published: April 19, 2024
CHMP5 attenuates osteoarthritis via inhibiting chondrocyte apoptosis and extracellular matrix degradation: involvement of NF-κB pathway.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 01, 2023
The CDK4/6 Inhibitor Palbociclib Synergizes with ATRA to Induce Differentiation in AML.
Journal: Molecular cancer therapeutics
Published: August 17, 2023
Comparison of first-line treatments for elderly patients with diffuse large B-cell lymphoma: A systematic review and network meta-analysis.
Journal: Frontiers in immunology
Published: October 28, 2022
Palbociclib enhances the effect of doxorubicin-induced apoptosis in activated B-cell-like diffuse large B-cell lymphoma cells.
Journal: Anti-cancer drugs
Published: October 07, 2022
Elevated circulating myeloid-derived suppressor cells associated with poor prognosis in B-cell non-Hodgkin's lymphoma patients.
Journal: Immunity, inflammation and disease
Published: December 26, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026